187 related articles for article (PubMed ID: 22148938)
1. Emerging adenosine receptor agonists: an update.
Gao ZG; Jacobson KA
Expert Opin Emerg Drugs; 2011 Dec; 16(4):597-602. PubMed ID: 22148938
[TBL] [Abstract][Full Text] [Related]
2. Emerging adenosine receptor agonists.
Gao ZG; Jacobson KA
Expert Opin Emerg Drugs; 2007 Sep; 12(3):479-92. PubMed ID: 17874974
[TBL] [Abstract][Full Text] [Related]
3. Introduction to adenosine receptors as therapeutic targets.
Jacobson KA
Handb Exp Pharmacol; 2009; (193):1-24. PubMed ID: 19639277
[TBL] [Abstract][Full Text] [Related]
4. Recent progress in the development of adenosine receptor ligands as antiinflammatory drugs.
Akkari R; Burbiel JC; Hockemeyer J; Müller CE
Curr Top Med Chem; 2006; 6(13):1375-99. PubMed ID: 16918456
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the myocardial blood flow response to regadenoson and dipyridamole: a quantitative analysis in patients referred for clinical 82Rb myocardial perfusion PET.
Goudarzi B; Fukushima K; Bravo P; Merrill J; Bengel FM
Eur J Nucl Med Mol Imaging; 2011 Oct; 38(10):1908-16. PubMed ID: 21656246
[TBL] [Abstract][Full Text] [Related]
6. Adenosine receptor ligands-recent developments part I. Agonists.
Muller CE
Curr Med Chem; 2000 Dec; 7(12):1269-88. PubMed ID: 11032971
[TBL] [Abstract][Full Text] [Related]
7. Recent developments in adenosine receptor ligands and their potential as novel drugs.
Müller CE; Jacobson KA
Biochim Biophys Acta; 2011 May; 1808(5):1290-308. PubMed ID: 21185259
[TBL] [Abstract][Full Text] [Related]
8. A(2A) adenosine receptors are differentially modulated by pharmacological treatments in rheumatoid arthritis patients and their stimulation ameliorates adjuvant-induced arthritis in rats.
Vincenzi F; Padovan M; Targa M; Corciulo C; Giacuzzo S; Merighi S; Gessi S; Govoni M; Borea PA; Varani K
PLoS One; 2013; 8(1):e54195. PubMed ID: 23326596
[TBL] [Abstract][Full Text] [Related]
9. Pain-relieving prospects for adenosine receptors and ectonucleotidases.
Zylka MJ
Trends Mol Med; 2011 Apr; 17(4):188-96. PubMed ID: 21236731
[TBL] [Abstract][Full Text] [Related]
10. Contributions of A2A and A2B adenosine receptors in coronary flow responses in relation to the KATP channel using A2B and A2A/2B double-knockout mice.
Sanjani MS; Teng B; Krahn T; Tilley S; Ledent C; Mustafa SJ
Am J Physiol Heart Circ Physiol; 2011 Dec; 301(6):H2322-33. PubMed ID: 21949117
[TBL] [Abstract][Full Text] [Related]
11. Effects of caffeine intake prior to stress cardiac magnetic resonance perfusion imaging on regadenoson- versus adenosine-induced hyperemia as measured by T1 mapping.
van Dijk R; Kuijpers D; Kaandorp TAM; van Dijkman PRM; Vliegenthart R; van der Harst P; Oudkerk M
Int J Cardiovasc Imaging; 2017 Nov; 33(11):1753-1759. PubMed ID: 28547666
[TBL] [Abstract][Full Text] [Related]
12. Adenosine and protection from acute kidney injury.
Yap SC; Lee HT
Curr Opin Nephrol Hypertens; 2012 Jan; 21(1):24-32. PubMed ID: 22080856
[TBL] [Abstract][Full Text] [Related]
13. Adenosine receptor agonists: from basic medicinal chemistry to clinical development.
Yan L; Burbiel JC; Maass A; Müller CE
Expert Opin Emerg Drugs; 2003 Nov; 8(2):537-76. PubMed ID: 14662005
[TBL] [Abstract][Full Text] [Related]
14. P1 Receptor Agonists/Antagonists in Clinical Trials - Potential Drug Candidates of the Future.
Borah P; Deka S; Mailavaram RP; Deb PK
Curr Pharm Des; 2019; 25(26):2792-2807. PubMed ID: 31333097
[TBL] [Abstract][Full Text] [Related]
15. Medicinal Chemistry and Therapeutic Potential of Agonists, Antagonists and Allosteric Modulators of A1 Adenosine Receptor: Current Status and Perspectives.
Deb PK; Deka S; Borah P; Abed SN; Klotz KN
Curr Pharm Des; 2019; 25(25):2697-2715. PubMed ID: 31333094
[TBL] [Abstract][Full Text] [Related]
16. Systemic adenosine given after ischemia protects renal function via A(2a) adenosine receptor activation.
Lee HT; Emala CW
Am J Kidney Dis; 2001 Sep; 38(3):610-8. PubMed ID: 11532695
[TBL] [Abstract][Full Text] [Related]
17. Medicinal chemistry of adenosine, P2Y and P2X receptors.
Jacobson KA; Müller CE
Neuropharmacology; 2016 May; 104():31-49. PubMed ID: 26686393
[TBL] [Abstract][Full Text] [Related]
18. Applications of adenosine receptor ligands in medical imaging by positron emission tomography.
Holschbach MH; Olsson RA
Curr Pharm Des; 2002; 8(26):2345-52. PubMed ID: 12369949
[TBL] [Abstract][Full Text] [Related]
19. On the role of subtype selective adenosine receptor agonists during proliferation and osteogenic differentiation of human primary bone marrow stromal cells.
Costa MA; Barbosa A; Neto E; Sá-e-Sousa A; Freitas R; Neves JM; Magalhães-Cardoso T; Ferreirinha F; Correia-de-Sá P
J Cell Physiol; 2011 May; 226(5):1353-66. PubMed ID: 20945394
[TBL] [Abstract][Full Text] [Related]
20. Adenosine Receptors as Novel Targets for the Treatment of Various Cancers.
Gorain B; Choudhury H; Yee GS; Bhattamisra SK
Curr Pharm Des; 2019; 25(26):2828-2841. PubMed ID: 31333092
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
